PROS1 and infection: A modified serological enzyme-linked immunosorbent assays (ELISA) assay developed by Krammer and colleagues [9,10] was implemented to examine 9,550 individuals of age rage 16–91 years old for SARS-CoV-2 S protein IgG antibodies to quantify rates of prior infection in the GCMA.